1,374 results on '"Tournaye H"'
Search Results
2. Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study
3. Impact of cell loss after warming of human vitrified day 3 embryos on obstetric outcome in single frozen embryo transfers
4. Circadian serum progesterone variations on the day of frozen embryo transfer in a modified natural cycle protocol
5. Embryo quality after sperm selection using density gradient centrifugation or microfluidic technology: a sibling oocyte study
6. First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome
7. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation
8. Enzymatic tissue processing after testicular biopsy in non-obstructive azoospermia enhances sperm retrieval
9. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
10. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
11. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
12. Screening naar Chlamydia trachomatis bij allogene spermadonoren: is het noodzakelijk om elke donatie te testen of volstaan periodieke tests?
13. In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation
14. P-649 Circadian serum progesterone variations on the day of frozen embryo transfer in artificially prepared cycles
15. O-130 Initiation of ovarian stimulation in the late follicular phase, a randomized controlled trial
16. P-784 First trimester screening for preterm preeclampsia after ART: high risk, high gain?
17. P-080 Enzymatic tissue processing after testicular biopsy in non-obstructive azoospermia enhances sperm retrieval and cumulative live birth rates
18. EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
19. Individualised luteal phase support using additional oral dydrogesterone in artificially prepared cycles for frozen embryo transfer: does it offer any benefit?
20. Spermatogenesis after gonadotoxic childhood treatment: follow-up of 12 patients
21. Does the dose or type of gonadotropins affect the reproductive outcomes of poor responders undergoing modified natural cycle IVF (MNC-IVF)?
22. Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary?
23. Correction to: EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third‑ versus second‑generation estradiol and progesterone immunoassays
24. The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders
25. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger
26. Impact of Late-Follicular Phase Elevated Serum Progesterone on Cumulative Live Birth Rates: Is There a Deleterious Effect on Embryo Quality?
27. Chromosomal abnormalities in 1663 infertile men with azoospermia: the clinical consequences
28. Frozen embryo transfer: a review on the optimal endometrial preparation and timing
29. Male Contributions to the Biology of Conception and Fertilization
30. P-660 Polymorphisms in FSHR gene do not affect late follicular phase steroidogenic response in predicted normoresponders. Secondary analysis of a prospective multicenter cohort study
31. P-780 Ten years electronic witnessing in the IVF laboratory
32. O-254 Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS): impact on endometrium and genital tract microbiota
33. P-662 Association between polymorphisms in FSHR and reproductive outcomes following IVF. Secondary analysis of a prospective cohort study in Europe and Asia
34. O-046 Reproductive prospects for ICSI children
35. P-321 Culturomics-generated vaginal and endometrial microbiome profiles in subfertile patients
36. P-401 The impact of the recipients’ age in vitrified/warmed oocyte donation (OD) cycles
37. O-239 CD147 expression in human embryos and its role during implantation
38. P-671 Progestin primed ovarian stimulation using dydrogesterone in oocyte donation cycles: a longitudinal study
39. O-069 Does dual stimulation with continuous FSH administration increase the total number of metaphase II oocytes in poor responders?
40. P-087 Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis
41. P-253 Shorter duration of compaction during human in-vitro preimplantation embryo development is associated with a higher clinical pregnancy rate
42. P-764 Is children’s health up to two years of age affected by embryo vitrification?
43. P-669 The impact of luteal phase support on pregnancy outcomes in relation to serum progesterone levels on the day of frozen embryo transfer in natural cycles
44. Deposition of the spermatozoon in the human oocyte at ICSI: impact on oocyte survival, fertilization and blastocyst formation
45. Mutation analysis of three genes in patients with maturation arrest of spermatogenesis and couples with recurrent miscarriages
46. Cumulative live birth rate following ovarian stimulation with freeze-all in women with polycystic ovaries: does the PCOS phenotype have an impact?
47. Maternally inherited differences in mitochondrial DNA genotype between ART and spontaneously conceived individuals associate with low birthweight
48. Short (seven days) versus conventional (fourteen days) estrogen priming in an artificial frozen embryo transfer cycle: a randomised controlled trial
49. Cumulative live birth rate after a freeze-all approach in women with polycystic ovaries: does the PCOS phenotype have an impact?
50. Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: a double blind, cross-over, pharmacokinetic study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.